| Financial Year |
March 31 2023 |
| Monetary Funds |
1,977,682,750.49 |
| Held-for-trading Financial Assets |
746,587,034.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
36,551,599.65 |
| Advances to Suppliers |
57,549,041.03 |
| Other Receivables |
71,527,292.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,278,413,969.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,330,469.71 |
| Total Current Assets |
4,347,981,961.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,804,104,438.22 |
| Under-construction Projects |
303,500,679.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,708,101,922.08 |
| R&D expenses |
-- |
| Goodwill |
452,365,699.74 |
| Long-Term Deferred and Prepaid Expenses |
25,454,699.16 |
| Deferred Income Tax Assets |
143,322,485.33 |
| Other Non-Current Assets |
78,860,340.48 |
| Sub-Total of Non-Current Assets |
10,577,529,581.79 |
| Total Assets |
14,925,511,543.44 |
| Short-Term Loans |
839,569,611.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
637,170,280.28 |
| Accounts Payable |
129,825,216.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,095,536.35 |
| Taxes Payable |
162,177,694.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
274,006,050.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,050,550.06 |
| Other Current Liabilities |
1,414,409.95 |
| Sub-Total of Current Liabilities |
2,161,239,081.79 |
| Long-term Loans |
94,123,505.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
157,027,076.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
43,145,936.78 |
| Deferred Income Tax Liabilities |
236,643,116.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
551,597,514.96 |
| Total Liabilities |
2,712,836,596.75 |
| Paid-In Capital(Or Share Stock) |
2,776,722,265.00 |
| Capital Surplus |
4,431,079,021.81 |
| Surplus Reserve |
551,831,400.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,659,615,049.81 |
| Minority Stockholder's Interest |
1,784,446,254.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,428,228,692.06 |
| Owner's Equity（Stockholder's Equity） |
12,212,674,946.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,925,511,543.44 |
